Evaluation of the efficiency of combined antiviral therapy in COVID-19 challenging immunocompromised patients

Abstract There is limited data on the efficacy of combined antiviral treatment for immunosuppressed COVID-19 patients. We describe the clinical and microbiological outcomes of a cohort of oncohaematological patients with persistent SARS-CoV-2 infection who received different dual and triple antivira...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Marta López-Llaría, Francisco Tejerina, María Ferris, Isabel Regalado-Artamendi, Guadalupe Bernal, Pilar Catalán, Cristina Veintimilla, Lara Mesones, Leire Perez Latorre, Chiara Fanciulli, Teresa Aldamiz, Cristina Diez, Roberto Alonso, Patricia Muñoz, Laura Pérez-Lago, Darío García de Viedma, Gregorio Marañón Microbiology-ID COVID 19 Study Group
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Nature Portfolio 2026-02-01
coleção:	Scientific Reports
Assuntos:	COVID-19 SARS-CoV-2 Antiviral Combined therapy Genomics
Acesso em linha:	https://doi.org/10.1038/s41598-026-37430-0
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!